A selective CREB inhibitor, 666-15 (HY-101120, MedChemExpress), was purchased and used in our experimental design to treat MDA-MB-231 cells at a concentration of 73 nM. A pan-PKC inhibitor (Go 6983, Selleck) was purchased and used to treat MDA-MB-231 cells at a concentration of 5 μM.

Note: The content above has been extracted from a research article, so it may not display correctly.

Please log in to submit your questions online.
Your question will be posted on the Bio-101 website. We will send your questions to the authors of this protocol and Bio-protocol community members who are experienced with this method. you will be informed using the email address associated with your Bio-protocol account.

We use cookies on this site to enhance your user experience. By using our website, you are agreeing to allow the storage of cookies on your computer.